AMARIN CORP PLC\UK cotiza a 11.43 USD y tiene una capitalización bursátil de $240M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. It offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing tr…
| Periodo | 2026-10 | 2026-07 | 2026-04 | 2026-02 |
|---|---|---|---|---|
| Real | — | $-0.02 | — | $0.01 |
| Estimado | $-0.04 | $-0.01 | $0.17 | $0.07 |
| Sorpresa | — | -100.0% | — | -85.7% |
| Métrica | AMRN | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 56.6% | 57.0% | -0.5% |
| Operating Margin | -23.5% | -38.6% | +15.1% |
| Net Margin | -18.2% | -33.6% | +15.4% |
| FCF Margin | — | -13.9% | — |
| ROE | -8.4% | -40.4% | +31.9% |
| ROA | -5.8% | -32.0% | +26.2% |
| Current Ratio | 3.34 | 2.84 | +0.50 |
| Debt / Equity | — | 0.28 | — |